SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

20 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 423.30 millions, about 15.12% up against Rs. 367.70 millions recorded during the year-ago period.Modest increase of 12.50% in the Net Profit was reported from. 37.60 millions to Rs. 42.30  millions.OP of the company witnessed a marginal growth to 94.50 millions from 72.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 423.30 367.70 15.12 1782.60 1685.20 5.78 1782.60 1685.20 5.78
Other Income 122.70 129.80 -5.47 509.40 459.80 10.79 509.40 459.80 10.79
PBIDT 94.50 72.40 30.52 395.60 193.20 104.76 395.60 193.20 104.76
Interest 9.90 10.30 -3.88 39.60 43.60 -9.17 39.60 43.60 -9.17
PBDT 82.10 62.10 32.21 307.20 87.10 252.70 307.20 87.10 252.70
Depreciation 23.00 21.10 9.00 86.70 89.40 -3.02 86.70 89.40 -3.02
PBT 59.10 41.00 44.15 220.50 -2.30 -9686.96 220.50 -2.30 -9686.96
TAX 16.80 3.40 394.12 62.50 -8.60 -826.74 62.50 -8.60 -826.74
Deferred Tax 5.70 3.40 67.65 23.70 -13.20 -279.55 23.70 -13.20 -279.55
PAT 42.30 37.60 12.50 158.00 6.30 2407.94 158.00 6.30 2407.94
Equity 500.60 498.90 0.34 500.60 498.90 0.34 500.60 498.90 0.34
PBIDTM(%) 22.32 19.69 13.38 22.19 11.46 93.57 22.19 11.46 93.57

Viyash Scientific Share Price

208.90 -3.00 (-1.42%)
24-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.50
Dr. Reddys Lab 1312.40
Cipla 1295.00
Zydus Lifesciences 930.00
Lupin 2285.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×